HIMZX | VSTBX | HIMZX / VSTBX | |
Total Expense Ratio | 0.75 | 0.04 | 1,875% |
Annual Report Gross Expense Ratio | 0.93 | 0.04 | 2,325% |
Fund Existence | 26 years | 16 years | - |
Gain YTD | 2.974 | 3.550 | 84% |
Front Load | 2% | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 454M | 41.5B | 1% |
Annual Yield % from dividends | 4.30 | 4.18 | 103% |
Returns for 1 year | 6.42 | 6.81 | 94% |
Returns for 3 years | 16.04 | 14.78 | 109% |
Returns for 5 years | 13.21 | 10.14 | 130% |
Returns for 10 years | 26.47 | 28.79 | 92% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GAFFX | 82.92 | 0.81 | +0.99% |
American Funds Growth Fund of Amer F3 | |||
WFTCX | 5.21 | 0.05 | +0.97% |
Allspring Innovation Fund - Class C | |||
JOEMX | 13.50 | 0.06 | +0.45% |
JOHCM Emerging Markets Opps Instl | |||
JFNSX | 62.64 | 0.05 | +0.08% |
Janus Henderson Global Life Sciences S | |||
EUGCX | 26.12 | -0.05 | -0.19% |
Morgan Stanley Europe Opportunity L |